These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32053505)

  • 41. [Bacteremia due to Escherichia coli: epidemiological analysis and sensitivity to antibiotics in a county hospital].
    Javaloyas M; García-Somoza D; Gudiol F
    Med Clin (Barc); 2003 Feb; 120(4):125-7. PubMed ID: 12605835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
    Malande OO; Nuttall J; Pillay V; Bamford C; Eley B
    PLoS One; 2019; 14(9):e0222675. PubMed ID: 31550295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013.
    Zhao SY; Wang YC; Xiao SZ; Jiang XF; Guo XK; Ni YX; Han LZ
    Infect Dis (Lond); 2015 May; 47(5):310-8. PubMed ID: 25712794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
    Ivády B; Kenesei É; Tóth-Heyn P; Kertész G; Tárkányi K; Kassa C; Ujhelyi E; Mikos B; Sápi E; Varga-Heier K; Guóth G; Szabó D
    Infection; 2016 Jun; 44(3):309-21. PubMed ID: 26546372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteraemia due to AmpC β-lactamase-producing Escherichia coli in hospitalized cancer patients: risk factors, antibiotic therapy, and outcomes.
    Zhang Q; Zhang W; Li Z; Bai C; Li D; Zheng S; Zhang P; Zhang S
    Diagn Microbiol Infect Dis; 2017 Jul; 88(3):247-251. PubMed ID: 28434898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
    Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
    Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Severe sepsis and septic shock by Escherichia coli, clinical and microbiological analysis in Medellin, Colombia].
    Restrepo-Álvarez CA; Bernal E; Ascuntar-Tello J; Jaimes F
    Rev Chilena Infectol; 2019 Aug; 36(4):447-454. PubMed ID: 31859768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
    Xiao T; Wu Z; Shi Q; Zhang X; Zhou Y; Yu X; Xiao Y
    J Glob Antimicrob Resist; 2019 Jun; 17():147-156. PubMed ID: 30634054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 58. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia.
    Ouyang W; Li X; Wan Q; Ye Q
    Hepatogastroenterology; 2015; 62(138):346-9. PubMed ID: 25916061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Risk factors for bloodstream infections in liver or kidney transplantation recipients].
    Wan Q; Xiao X; Ye Q; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):924-7. PubMed ID: 23000768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.